Filter
1595
Filtered Results: 1595
Text search:
US
Pharmacist
Featured
Recommendations
126
New Publications
409
Language
Document type
No document type
831
Studies & Reports
348
Guidelines
197
Manuals
74
Strategic & Response Plan
58
Fact sheets
29
Training Material
23
Situation Updates
12
Resource Platforms
12
Brochures
6
Infographics
5
Countries / Regions
Global
72
India
67
Kenya
53
Ethiopia
48
South Africa
40
Liberia
36
Sierra Leone
35
Uganda
33
Nigeria
30
Rwanda
28
Western and Central Europe
28
Africa
25
Ghana
23
Zambia
21
Nepal
19
Bangladesh
19
Namibia
19
Syria
18
Tanzania
18
Ukraine
17
Malawi
17
Latin America and the Carribbean
13
Eastern Europe
13
Myanmar / Burma
13
Lesotho
12
Asia
12
Philippines
11
West and Central Africa
11
Zimbabwe
10
Cambodia
10
South–East Asia Region
10
Congo, Democratic Republic of
9
Botswana
9
Indonesia
9
Guinea
8
Germany
8
East and Southern Africa
8
Eswatini/ Swaziland
8
Cameroon
7
Haiti
7
Venezuela
7
South Sudan
7
Thailand
6
Burkina Faso
6
Mozambique
6
Russia
6
Vietnam
5
Brazil
5
Benin
4
Laos
4
Senegal
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Pakistan
4
Chile
3
Albania
3
Afghanistan
3
USA
3
Jordan
3
North America
3
United Kingdom
3
Papua New Guinea
3
China
2
Peru
2
Lithuania
2
Jamaica
2
Lebanon
2
Moldova
2
Sri Lanka
2
Georgia
2
Central African Republic
2
Mali
2
Iraq
2
Somalia
2
North Macedonia
1
Switzerland
1
Colombia
1
El Salvador
1
Turkey
1
Canada
1
Fiji
1
Estonia
1
Kyrgyzstan
1
Niger
1
Burundi
1
Qatar
1
Bulgaria
1
Hungary
1
Ireland
1
Western Pacific Region
1
Paraguay
1
Gabon
1
France
1
Portugal
1
Southern Africa
1
Bolivia
1
Argentina
1
Egypt
1
Sudan
1
Romania
1
Slovakia
1
Poland
1
Angola
1
Chad
1
Libya
1
Bhutan
1
Ecuador
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
607
Clinical Guidelines
119
Public Health
86
Key Resources
70
Women & Child Health
45
Pharmacy & Technologies
24
Capacity Building
21
Annual Report MEDBOX
2
Toolboxes
AMR
141
COVID-19
137
HIV
108
Pharmacy
104
Mental Health
100
TB
88
NCDs
45
Caregiver
42
NTDs
41
Ebola & Marburg
37
Rapid Response
36
Planetary Health
33
Conflict
29
Global Health Education
29
Health Financing Toolbox
28
Refugee
17
Disability
16
Specific Hazards
7
Natural Hazards
5
Zika
5
Polio
5
Social Ethics
4
Cholera
2
Schistosomiasis is a public health problem in tropical and subtropical regions of Africa, Asia, the Caribbean and South America. It is one of the neglected tropical diseases (NTDs) - a group of diseases and conditions that affect particularly low-income populations, worldwide.
Last year, WHO laun...
This paper has been prepared to inform discussion at the conference “Beating the DRUM - Domestic Resource Use and Mobilization for accelerating progress towards SDG3,”. Many countries face critical shortfalls in domestic resource use and mobilization (DRUM) for health, threatening to push health...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic factors, environmental factors, factors of medical co...
Harmonising proven strategies beyond the emergency phase. Zero Hunger Phase 2
In Vietnam, most of the examination and treatment facilities are facing with of spread of bacteria resistant to many antibiotics. The level and speed of drug resistance are increasing, at alarming level. The burden of drug resistance is increasing due to the increasing cost of treatment, prolonged t...
orientations provisoires, 14 juin 2021
Consideraciones para aplicar y ajustar medidas de salud pública y sociales en el contexto de la COVID-19
recommended
orientaciones provisionales, 14 de junio de 2021
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
COVID-19 has altered health sector capacity in low-income and middle-income countries (LMICs). Cost data to inform evidence-based priority setting are urgently needed. Consequently, in this paper, we calculate the full economic health sector costs of COVID-19 clinical management in 79 LMICs under di...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection prevention and control (IPC). This living guideline...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden and control in the WHO African region. It tra...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati...
Considerations on the implementation and adjustment of
public health and social measures in the context of
COVID-19
Interim guidance 14 June 2021
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
PLOS ONE | DOI:10.1371/journal.pone.0155525 May 19, 2016, 1 / 11
